| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ULTRASMEDBIO.2020.01.027 |
| P698 | PubMed publication ID | 32169397 |
| P2093 | author name string | Mark Borden | |
| Michel Versluis | |||
| Eleanor Stride | |||
| Thierry Bettinger | |||
| Samir Cherkaoui | |||
| Tim Segers | |||
| Guillaume Lajoinie | |||
| P2860 | cites work | Oscillatory Dynamics and In Vivo Photoacoustic Imaging Performance of Plasmonic Nanoparticle-Coated Microbubbles | Q27330273 |
| Ultrasound-Propelled Nanocups for Drug Delivery. | Q30396815 | ||
| Ultrasound-modulated fluorescence based on fluorescent microbubbles | Q30405170 | ||
| The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure | Q30407897 | ||
| Engineering optically triggered droplets for photoacoustic imaging and therapy | Q30421094 | ||
| Pulsed ultrasound enhances the delivery of nitric oxide from bubble liposomes to ex vivo porcine carotid tissue. | Q30428065 | ||
| Biogenic gas nanostructures as ultrasonic molecular reporters | Q30429916 | ||
| Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging | Q30435670 | ||
| Theranostic Gd(III)-lipid microbubbles for MRI-guided focused ultrasound surgery | Q30438087 | ||
| Ultrasound molecular imaging with targeted microbubble contrast agents | Q30445036 | ||
| Influence of lipid shell physicochemical properties on ultrasound-induced microbubble destruction | Q30446982 | ||
| Functionalized multiwalled carbon nanotubes as ultrasound contrast agents | Q30455580 | ||
| Effect of surface architecture on in vivo ultrasound contrast persistence of targeted size-selected microbubbles | Q30457849 | ||
| Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter | Q30461828 | ||
| Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound | Q30463873 | ||
| The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfaces | Q30464013 | ||
| Effect of anesthesia carrier gas on in vivo circulation times of ultrasound microbubble contrast agents in rats | Q30467900 | ||
| Role of Surface Tension in Gas Nanobubble Stability Under Ultrasound. | Q51745998 | ||
| Enhancement of microbubble mediated gene delivery by simultaneous exposure to ultrasonic and magnetic fields. | Q51780768 | ||
| Microbubble spectroscopy of ultrasound contrast agents. | Q51922420 | ||
| Dissolution of multicomponent microbubbles in the bloodstream: 1. Theory. | Q52238315 | ||
| Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. | Q52591101 | ||
| Ultrasound contrast plane wave imaging. | Q52632400 | ||
| Oxygen carrying microbubbles for enhanced sonodynamic therapy of hypoxic tumours. | Q52969106 | ||
| In situ targeted activation of an anticancer agent using ultrasound-triggered release of composite droplets. | Q53352159 | ||
| Nanobubbles from gas-generating polymeric nanoparticles: ultrasound imaging of living subjects. | Q53486698 | ||
| Three-dimensional transcranial microbubble imaging for guiding volumetric ultrasound-mediated blood-brain barrier opening. | Q55286921 | ||
| XVI.On musical air-bubbles and the sounds of running water | Q56535340 | ||
| Microbubble formation and pinch-off scaling exponent in flow-focusing devices | Q56990547 | ||
| Nonlinear Shell Behavior of Phospholipid-Coated Microbubbles | Q56990652 | ||
| Formation of dispersions using “flow focusing” in microchannels | Q57258632 | ||
| Micro-droplet formation utilizing microfluidic flow focusing and controllable moving-wall chopping techniques | Q57258634 | ||
| Microfluidic Fabrication of Stable Gas-Filled Microcapsules for Acoustic Contrast Enhancement | Q57425365 | ||
| In Vivo Demonstration of Cancer Molecular Imaging with Ultrasound Radiation Force and Buried-Ligand Microbubbles | Q57425766 | ||
| High-precision acoustic measurements of the nonlinear dilatational elasticity of phospholipid coated monodisperse microbubbles | Q57789029 | ||
| Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents | Q58072131 | ||
| Reverse engineering the ultrasound contrast agent | Q58564835 | ||
| Quantification of microbubble concentration through x-ray phase contrast imaging | Q60455375 | ||
| Sonothrombolysis with Magnetically Targeted Microbubbles | Q63547121 | ||
| Microbubbles, Nanodroplets and Gas-Stabilizing Solid Particles for Ultrasound-Mediated Extravasation of Unencapsulated Drugs: An Exposure Parameter Optimization Study | Q63547125 | ||
| Gas-Stabilizing Gold Nanocones for Acoustically Mediated Drug Delivery | Q63547160 | ||
| Identification of ultrasound echoes from the left ventricle by use of intracardiac injections of indocyanine green | Q68452148 | ||
| Contrast Agents for Diagnostic Ultrasound | Q69399580 | ||
| Ultrasonic detection of cavitation at catheter tips | Q71562517 | ||
| Gas-filled lipid bilayers as ultrasound contrast agents | Q72721963 | ||
| Acoustic droplet vaporization for therapeutic and diagnostic applications | Q73128945 | ||
| Perfectly monodisperse microbubbling by capillary flow focusing | Q77519270 | ||
| Role of the channel geometry on the bubble pinch-off in flow-focusing devices | Q80585990 | ||
| Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging | Q83733402 | ||
| BR38, a new ultrasound blood pool agent | Q83843554 | ||
| Monodisperse, submicrometer droplets via condensation of microfluidic-generated gas bubbles | Q84381856 | ||
| Secondary bjerknes forces deform targeted microbubbles | Q85950768 | ||
| Click Conjugation of Cloaked Peptide Ligands to Microbubbles | Q88256672 | ||
| Monodisperse Versus Polydisperse Ultrasound Contrast Agents: Non-Linear Response, Sensitivity, and Deep Tissue Imaging Potential | Q88503783 | ||
| Multicore Liquid Perfluorocarbon-Loaded Multimodal Nanoparticles for Stable Ultrasound and 19F MRI Applied to In Vivo Cell Tracking | Q90054602 | ||
| Improved coalescence stability of monodisperse phospholipid-coated microbubbles formed by flow-focusing at elevated temperatures | Q90234176 | ||
| Intermolecular Forces Model for Lipid Microbubble Shells | Q90449783 | ||
| Ultrasound-Responsive Conversion of Microbubbles to Nanoparticles to Enable Background-Free in Vivo Photoacoustic Imaging | Q90614506 | ||
| The Role of Ultrasound-Driven Microbubble Dynamics in Drug Delivery: From Microbubble Fundamentals to Clinical Translation | Q91088235 | ||
| Direct Evidence of Multibubble Sonoluminescence Using Therapeutic Ultrasound and Microbubbles | Q91915890 | ||
| The Optimized Fabrication of a Novel Nanobubble for Tumor Imaging | Q92862468 | ||
| Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model | Q30475139 | ||
| Controllable microfluidic synthesis of multiphase drug-carrying lipospheres for site-targeted therapy | Q30480712 | ||
| Preparation of suspensions of phospholipid-coated microbubbles by coaxial electrohydrodynamic atomization | Q30482783 | ||
| Dynamic microPET imaging of ultrasound contrast agents and lipid delivery | Q30485366 | ||
| A stimulus-responsive contrast agent for ultrasound molecular imaging | Q30491503 | ||
| On-chip generation of microbubbles as a practical technology for manufacturing contrast agents for ultrasonic imaging | Q30496810 | ||
| Magnetic resonance properties of Gd(III)-bound lipid-coated microbubbles and their cavitation fragments. | Q30572572 | ||
| Evaluation of microbubble contrast agents for dynamic imaging with x-ray phase contrast | Q30659317 | ||
| Mechanisms of contrast agent destruction | Q30670243 | ||
| MR perfusion imaging using encapsulated laser-polarized 3He. | Q31008705 | ||
| Nanomechanical probing of microbubbles using the atomic force microscope | Q33295132 | ||
| Quantum-dot-modified microbubbles with bi-mode imaging capabilities | Q33506582 | ||
| Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging | Q33904256 | ||
| Characteristics of SonoVuetrade mark | Q33933166 | ||
| Echocardiography of the aortic root | Q34054071 | ||
| Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging | Q34123101 | ||
| Contrast enhanced vascular three-dimensional ultrasound imaging | Q34771375 | ||
| Optically induced resonance of nanoparticle-loaded microbubbles | Q35198072 | ||
| Microbubble ultrasound contrast agents: a review | Q35619392 | ||
| The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging | Q36022403 | ||
| Molecular ultrasound imaging using microbubble contrast agents | Q36849668 | ||
| Maintaining monodispersity in a microbubble population formed by flow-focusing | Q36914927 | ||
| Pharmaceutical quality by design: product and process development, understanding, and control | Q37054214 | ||
| Toward theragnostics | Q37356889 | ||
| Cardiovascular drug delivery with ultrasound and microbubbles | Q38187761 | ||
| Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals | Q38239959 | ||
| Characterisation of Contrast Agent Microbubbles for Ultrasound Imaging and Therapy Research | Q38766881 | ||
| Pharmacokinetics of Perfluorobutane after Intra-Venous Bolus Injection of Sonazoid in Healthy Chinese Volunteers. | Q38914204 | ||
| First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study | Q38931014 | ||
| Ultrasound and microbubble mediated drug delivery: acoustic pressure as determinant for uptake via membrane pores or endocytosis. | Q38934913 | ||
| Characteristics and Echogenicity of Clinical Ultrasound Contrast Agents: An In Vitro and In Vivo Comparison Study | Q38939874 | ||
| Ultrasound-aided microbubbles facilitate the delivery of drugs to the inner ear via the round window membrane | Q39470955 | ||
| Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery. | Q39583871 | ||
| Galactose-based intravenous sonographic contrast agent: experimental studies | Q41070693 | ||
| Perflenapent emulsion (EchoGen): a new long-acting phase-shift agent for contrast echocardiography | Q41651593 | ||
| Microfluidic Assembly of Monodisperse, Nanoparticle-Incorporated Perfluorocarbon Microbubbles for Medical Imaging and Therapy | Q42953831 | ||
| Gd-DTPA-loaded PLGA microbubbles as both ultrasound contrast agent and MRI contrast agent--a feasibility research | Q43131947 | ||
| Microbubble dissolution in a multigas environment | Q43196513 | ||
| Optimizing Sensitivity of Ultrasound Contrast-Enhanced Super-Resolution Imaging by Tailoring Size Distribution of Microbubble Contrast Agent | Q44873581 | ||
| Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents | Q44927479 | ||
| The acoustic signature of decaying resonant phospholipid microbubbles | Q45776758 | ||
| Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. | Q45940724 | ||
| Formation of bubbles and droplets in parallel, coupled flow-focusing geometries | Q46345446 | ||
| Test of the Epstein-Plesset model for gas microparticle dissolution in aqueous media: effect of surface tension and gas undersaturation in solution | Q46441298 | ||
| Post-Formation Shrinkage and Stabilization of Microfluidic Bubbles in Lipid Solution | Q46528945 | ||
| Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography | Q46673263 | ||
| Loss of gas from echogenic liposomes exposed to pulsed ultrasound | Q46942228 | ||
| Rapid shrinkage of lipid-coated bubbles in pulsed ultrasound | Q46991293 | ||
| Toward optimization of in vivo super-resolution ultrasound imaging using size-selected microbubble contrast agents. | Q47184117 | ||
| Universal Equations for the Coalescence Probability and Long-Term Size Stability of Phospholipid-Coated Monodisperse Microbubbles Formed by Flow Focusing | Q47190211 | ||
| Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts | Q47201361 | ||
| Microbubble size isolation by differential centrifugation. | Q47210345 | ||
| Influence of bubble size distribution on the echogenicity of ultrasound contrast agents: a study of SonoVue. | Q47224012 | ||
| Attenuation and size distribution measurements of Definity and manipulated Definity populations | Q47286860 | ||
| Pressure-dependent attenuation and scattering of phospholipid-coated microbubbles at low acoustic pressures. | Q47317643 | ||
| Engineered microsphere contrast agents for optical coherence tomography | Q47612390 | ||
| Nonspherical oscillations of ultrasound contrast agent microbubbles | Q47736407 | ||
| Liter-scale production of uniform gas bubbles via parallelization of flow-focusing generators. | Q47930477 | ||
| Laser-driven resonance of dye-doped oil-coated microbubbles: Experimental study | Q47956501 | ||
| A versatile method for the preparation of particle-loaded microbubbles for multimodality imaging and targeted drug delivery | Q48118371 | ||
| Effect of PEGylation on performance of protein microbubbles and its comparison with lipid microbubbles. | Q48392287 | ||
| Clinical trial of blood-brain barrier disruption by pulsed ultrasound | Q48674887 | ||
| Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results | Q49774225 | ||
| Enhancement and Passive Acoustic Mapping of Cavitation from Fluorescently Tagged Magnetic Resonance-Visible Magnetic Microbubbles In Vivo. | Q50239939 | ||
| Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. | Q50889971 | ||
| Air microbubbles as MR susceptibility contrast agent at 1.5 Tesla. | Q51099022 | ||
| Uniform scattering and attenuation of acoustically sorted ultrasound contrast agents: Modeling and experiments. | Q51117192 | ||
| More Than Bubbles: Creating Phase-Shift Droplets from Commercially Available Ultrasound Contrast Agents. | Q51140588 | ||
| Viability of endothelial cells after ultrasound-mediated sonoporation: Influence of targeting, oscillation, and displacement of microbubbles. | Q51226554 | ||
| Stability of Monodisperse Phospholipid-Coated Microbubbles Formed by Flow-Focusing at High Production Rates. | Q51422847 | ||
| Bubble sorting in pinched microchannels for ultrasound contrast agent enrichment. | Q51486324 | ||
| Preparation of monodisperse microbubbles using an integrated embedded capillary T-junction with electrohydrodynamic focusing. | Q51515701 | ||
| Acoustic bubble sorting for ultrasound contrast agent enrichment. | Q51519686 | ||
| Accounting for the stability of microbubbles to multi-pulse excitation using a lipid-shedding model. | Q51525752 | ||
| Expanding 3D geometry for enhanced on-chip microbubble production and single step formation of liposome modified microbubbles. | Q51537096 | ||
| Microbubble generation in a co-flow device operated in a new regime. | Q51550142 | ||
| Ultrasound-induced microbubble coalescence. | Q51571301 | ||
| Ultrasound-induced encapsulated microbubble phenomena. | Q51655897 | ||
| Acoustic Cluster Therapy (ACT)--A novel concept for ultrasound mediated, targeted drug delivery. | Q51706553 | ||
| P921 | main subject | microbubble | Q6839290 |
| P577 | publication date | 2020-03-10 | |
| P1433 | published in | Ultrasound in Medicine and Biology | Q2260380 |
| P1476 | title | Microbubble Agents: New Directions |
| Q100426163 | Monodisperse versus Polydisperse Ultrasound Contrast Agents: In Vivo Sensitivity and safety in Rat and Pig |
| Q96430850 | Ultrasound Contrast Agent Modeling: A Review |
| Q90277042 | Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery |
Search more.